Discovery and Characterization of 1H-1,2,3-Triazole Derivatives as Novel Prostanoid EP4 Receptor Antagonists for Cancer Immunotherapy-Reference-Cited by-同舟云学术

Discovery and Characterization of 1H-1,2,3-Triazole Derivatives as Novel Prostanoid EP4 Receptor Antagonists for Cancer Immunotherapy

Published:2019-12-19 Issue:2 Volume:63 Page:569-590
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Yang Jun-Jie¹^ORCID,Yu Wei-Wei¹,Hu Long-Long¹,Liu Wen-Juan¹,Lin Xian-Hua¹,Wang Wei¹,Zhang Qiansen¹^ORCID,Wang Pei-Li¹^ORCID,Tang Shuo-Wen¹,Wang Xin¹,Liu Mingyao¹^ORCID,Lu Weiqiang¹^ORCID,Zhang Han-Kun¹^ORCID

Affiliation:

1. Drug Discovery Unit, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai 200241, China

Funder

East China Normal University

Ministry of Science and Technology of the People's Republic of China

Shanghai Municipal Education Commission

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Shenzhen Municipality

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link